New York, NY -- November 14, 2018 -- InvestorsHub NewsWire -- via nextbigticker.com
Puration, Inc. (PURA) is rated BULLISH today by BullishInvestor.com after the company yesterday announced with Kali, Inc. (KALY) the first shipment of a private label CBD infused water with a custom extract from KALY.
Kali-Extracts and Puration Announce First Shipment Of Hemp-Derived CBD Infused Private Label Water For Pharmaceutical Client
From the PURA and KALY News
“… announced shipping the first private labeled, hemp-derived CBD infused, high alkaline water to Generex Biotechnology Corporation (OTCQB: GNBT) in conjunction with a previously announced agreement to produce $1 million of CBD infused water for Generex. PURA is producing the CBD infused water for Generex and PURA has in turn engaged KALY in a $300,000 contract to produce the CBD extract specific to the requirements of Generex.
KALY and HEMP Positioned To Benefit From $867 Billion Farm Bill
After Congress passed the $867 Billion Farm Bill legalizing hemp farming, KALY and Hemp, Inc. (HEMP) were both found on the OTCMarkets top 10 most active traders by share volume list. KALY is on the list again today, though HEMP has slipped down slightly while still in the top 20. Another company benefiting from the Farm Bill that hs moved up today’s top 10 list is USMJ. The large trading volumes at these levels is a reasonable indication that a base is building for bigger gains.
DISCLAIMER: NextBigTicker.com (NBT)is a third party publisher and news dissemination service provider. NBT is NOT affiliated in any manner with any company mentioned herein. NBT is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. NBT's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. NBT is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. NBT has not been compensated for this release and HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.